About Neuland Laboratories Ltd
Neuland Laboratories engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.
Founded
1984
CEO
D R Rao
Employees
3,881
HQ
Hyderabad, India
Finished Products
1Sales
₹4,712.49Cr2Bulk Drugs
₹881.25Cr3Sale of Services
₹206.60Cr4Scrap Sales
₹101.24Cr5Export Incentive
₹84.28Cr6Sale of Impurities
₹9.46CrRaw Materials
1Raw Material Consumed
₹1,394.57Cr2Packing Material
₹7.77CrAbout Neuland Laboratories Ltd
Neuland Laboratories engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.
Founded:1984
CEO:D R Rao
Employees:3,881
HQ:Hyderabad, India
Finished Products
1Sales
₹4,712.49Cr2Bulk Drugs
₹881.25Cr3Sale of Services
₹206.60Cr4Scrap Sales
₹101.24Cr5Export Incentive
₹84.28Cr6Sale of Impurities
₹9.46CrRaw Materials
1Raw Material Consumed
₹1,394.57Cr2Packing Material
₹7.77CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹23,881
52W Low
₹11,500
Volume39.70K
Avg VolumeN/A
Beta0.89
Dividend Yield0.15%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
59.37x
Valuation
P/B Ratio
15.77x
Valuation
EPS
₹387.98
Valuation
Dividend Yield
0.15%
Valuation
ROE
19.42%
Profitability
ROCE
23.57%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
23.9%
International
76.1%
USA and North America35.3%
Europe33.4%
India23.9%
Rest of the world7.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.16x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
9.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.